Research advances in primary biliary cirrhosis
10.3969/j.issn.1001-5256.2015.02.004
- VernacularTitle:原发性胆汁性肝硬化的过去、现在与未来
- Author:
Jiangyi ZHU
1
;
Ying HAN
Author Information
1. Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi′an 710032, China
- Publication Type:Research Article
- Keywords:
liver cirrhosis, biliary;
treatment outcome;
ursodeoxycholic acid
- From:
Journal of Clinical Hepatology
2015;31(2):163-
- CountryChina
- Language:Chinese
-
Abstract:
Primary biliary cirrhosis (PBC) is a chronic progressive cholestatic liver disease associated with immunity, with unknown etiology and pathogenesis. This article reviews the origin of its name, recent advances in research on PBC, and the prospect of treatment. Ursodeoxycholic acid is considered to be effective in improving cholestasis among PBC patients, but its naming and risk factors, as well as the response criteria and treatment, still need further research.
